SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
sulin
Lv1
1
30 积分
2022-08-08 加入
最近求助
最近应助
互助留言
A vision–language foundation model for precision oncology
3小时前
待确认
A genetic variant in gene NDUFAF4 confers the risk of non‐small cell lung cancer by perturbing hsa‐miR‐215 binding
9个月前
已完结
Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors
10个月前
已完结
Germinal immunogenetics as a predictive factor for immunotherapy
10个月前
已完结
Germline variants associated with toxicity to immune checkpoint blockade
10个月前
已完结
P2.05-05 Genomic Variants Associated with Response to Immune Checkpoint Inhibitors Amongst Asian Patients with Advanced NSCLC
10个月前
已完结
Glioblastoma Recurrence Patterns After Radiation Therapy With Regard to the Subventricular Zone
1年前
已完结
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups
1年前
已完结
Three-year follow-up and patient-reported outcomes from CheckMate 078: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer
1年前
已完结
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study
1年前
已完结
没有进行任何应助
点赞,速度真快
2年前
感谢,点赞
2年前
感谢,点赞,速度真快
2年前
速度真快
2年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论